Image optimize LCP
  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • mayo 02, 2023 1 lectura mínima

    Want to know how we help? 

    After years in the field, an international NGO supporting clinics in Tanzania, Uganda, Nigeria, and Haiti, had found that obstetric hemorrhage was one of the biggest preventable causes of maternal mortality. They were then looking to purchase the Non-Pneumatic Anti Shock Garment (NASG), a low-cost, evidence-based, first-aid device used to stabilize women experiencing obstetric hemorrhage. 

    After a thorough search, they found Maternova offered the best path to acquiring the NASG. During discussions with our team, Maternova offered tailored advice on how to best pair the NASG with other low-cost, life-saving devices designed to prevent obstetric hemorrhage, like the CRADLE Vitals Monitor and the Obstetric Ballon. Based on the recommendations made by Maternova’s Chief Medical Officer, Dr. Luna Mehrain, they ordered the three products and incorporated them into their health programs and training sessions. To ease the introduction of the products into the work of their medical teams in Tanzania, Uganda, and Nigeria (50 professionals in total), Dr. Luna Mehrain offered a custom, live training on best practices for the three products.

    This story is one of many where Maternova demonstrated a high level of medical expertise and efficiency to support its NGO clients. Paying close attention to medical innovations in this field, Maternova can offer tailored medical advice and products to your teams, supporting you in promoting maternal and neonatal health around the globe.

    Dejar un comentario

    Los comentarios se aprobarán antes de mostrarse.


    Ver artículo completo

    RAPIDIRON study of intravenous iron UN PHOTO
    Intravenous iron in the 2nd trimester: An innovative way to address anemia in pregnancy

    septiembre 10, 2025 2 lectura mínima

    "First-line treatment of moderate maternal iron deficiency anemia with single-dose infusion of intravenous iron results in a reduced incidence of low birth weight infants (intravenous ferric carboxymaltose vs oral) and a higher incidence of attaining maternal nonanemic state without use of additional iron or blood transfusion (intravenous ferric carboxymaltose and ferric derisomaltose vs oral)."

    Ver artículo completo
    Continuous Temperature Monitoring for a Ward full of Newborns
    Continuous Temperature Monitoring for a Ward full of Newborns

    agosto 26, 2025 2 lectura mínima

    Ver artículo completo
    A new baby-friendly dispersible anti-malarial is born
    A new baby-friendly dispersible anti-malarial is born

    julio 10, 2025 2 lectura mínima

    Coartem Baby, a dispersible anti-malarial 

    Ver artículo completo